Search
  • Biocelect

Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro

Updated: Jul 16

60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of

ARAKODA (tafenoquine) for COVID-19


Find full press release in attachment below

Tafenoquine Press Release July 2020pdf

Please find the link and attached document of the published article and findings below

https://www.biorxiv.org/content/10.1101/2020.07.12.199059v1

Dow et al 2020 TQ COVID 19 20200708pdf

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Privacy Policy

  • LinkedIn Social Icon